Paul Scott Hoffmann is a pharmacist who is specialized in Oncology in Everett, Washington. Patients can reach him at 1717 13th St, Everett or contact him on 425-297-5500. Active license number of Paul Scott Hoffmann is PH00014280 for Oncology in Washington. Paul Scott Hoffmann is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Paul Scott Hoffmann speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Paul Scott Hoffmann
Specialization:
Oncology
Credentials:
RPH, BCOP
Gender:
Male
Location:
1717 13th St, Everett, Washington, 98201
Phone:
425-297-5500
Fax:
425-297-5561
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Paul Scott Hoffmann are as mentioned below.
NPI Number:
1861913519
NPI Enumeration Date:
03 Jul, 2017
NPI Last Update On:
21 Jul, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Paul Scott Hoffmann are as mentioned below.
Specialization
License Number
State
Status
Oncology
PH00014280
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
12532 81st Pl Ne, Kirkland, Washington
Zip:
98034-2507
Phone Number:
425-269-2457
Fax Number:
--
Patients can reach Paul Scott Hoffmann at 1717 13th St, Everett, Washington or can call on phone at 425-297-5500.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.